A true contrarian play for the adventurous investor
Most investors wouldn't touch a Chinese-run alternative energy stock with a ten-foot barge pole, says Tom Bulford. But this particular stock might just be worth a punt.
Small company investors are no longer much interested in alternative energy. Many struggle to find their place in a business that is driven by highly unpredictable earnings. And that is especially true of Chinese companies. Many simply can't be trusted.
So for the true contrarian in you, how about a Chinese manufacturer of bioethanol refineries that will depend on a handful of projects this year and is controlled by a handful on Chinese investors?
If that is not enough to put the shares beyond the reach of even the longest bargepole, this is a business that is also highly sensitive to the price of oil and who knows where that is heading?
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
About as popular in London as chicken feet
As you might expect, shares of ChinaNew Energy(AIM: CNEL) are about as popular in London as a dish of chickens' feet. Since coming on to AIM a year ago at a price of 7p the share price has halved and the major shareholders are, I understand, looking for a bit more action and a greater appreciation of their efforts. They may have a point.
Let's look at the numbers first. At this share price, China New Energy is valued at just £11m, well below 2011's revenue of £15.4m and less than five times its recent annual rate of post-tax profitability. That is the sort of ungenerous rating normally applied to a business without much of a future, but that hardly seems to be the case here.
Bioethanol is a genuine alternative energy that can be mixed with conventional oil-based fuel without any appreciable dilution of performance. Already it is widely used as an additive in the USA, and the EU wants to see bioethanol provide 10% of road transport by 2020. So what is bioethanol?
Bioethanol is derived from biomass plants such as sugar cane and corn. It is an alcohol and if you have a sip it will blow your head off, which is why its main commercial purpose is as a source of energy. A decade or so ago there was quite a boom in bioethanol production, with many refineries built in the USA and several more in China. Today, that does not look too smart.
What happened to the bioethanol boom?
The diversion of food crops away from hungry mouths and into the petrol tank hardly seemed to be a humane use of scarce resources. But what really scuppered the business was rising food costs. Bioethanol producers found themselves having to pay more and more for their raw material crops, and with much of the industry dependent upon government subsidies, the numbers failed to add up.
Nowhere did this hit harder than in China. The domestic price of corn rose by 30% in 2007, and in response the Chinese government imposed a moratorium on any new ethanol production. That was bad news for China New Energy, which is the dominant supplier of bioethanol refineries in the country. However, the business is by no means dead. The Chinese government still wants to increase the share of bioethanol in the country's energy mix, and in future it can do so without plucking food out of hungry mouths.
New raw materials could lead to new prospects
The future of bioethanol lies with so-called second generation' refineries. Instead of taking food crops as a raw material, they use the parts of plants that are not eaten stems, stalks and husks.
Production of fuel from this cellulosic waste is promising to recharge the industry, and China New Energy appears to have more than enough expertise and experience to satisfy this demand. For the time being, it is only working on about three projects per year and that lends an inevitable degree of uncertainty to its financial results.
But it has reacted to the recent dip in business by winning its first contracts outside China, including in Russia and Romania, and by extending its range of services beyond basic bioethanol refineries. Today, it can offer to convert an older refinery into one equipped for second generation biofuels. It can construct plants to make an advanced version of bioethanol called biobutanol.
It has expertise in energy saving for existing plants and has completed some projects in return for a share in the value of the energy savings. It can take waste product from the production of bioethanol and turn it into valuable biogas through the process of anaerobic fermentation. And finally, it is looking to improve its capabilities in the supply of yeast, the key ingredient in the bioethanol process.
So China New Energy could be worth a closer look. I understand that a research analyst has recently been to see the operations in China and is preparing a report that should give some reassurance to City investors. Assuming his conclusions are favourable, this could mark a turning point for an unloved share. Watch this space.
This article is taken from Tom Bulford's free twice-weekly small-cap investment email The Penny Sleuth. Sign up to The Penny Sleuth here.
Information in Penny Sleuth is for general information only and is not intended to be relied upon by individual readers in making (or not making) specific investment decisions. Penny Sleuth is an unregulated product published by Fleet Street Publications Ltd.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Tom worked as a fund manager in the City of London and in Hong Kong for over 20 years. As a director with Schroder Investment Management International he was responsible for £2 billion of foreign clients' money, and launched what became Argentina's largest mutual fund. Now working from his home in Oxfordshire, Tom Bulford helps private investors with his premium tipping newsletter, Red Hot Biotech Alert.
-
Christmas at Chatsworth: review of The Cavendish Hotel at Baslow
MoneyWeek Travel Matthew Partridge gets into the festive spirit at The Cavendish Hotel at Baslow and the Christmas market at Chatsworth
By Dr Matthew Partridge Published
-
Tycoon Truong My Lan on death row over world’s biggest bank fraud
Property tycoon Truong My Lan has been found guilty of a corruption scandal that dwarfs Malaysia’s 1MDB fraud and Sam Bankman-Fried’s crypto scam
By Jane Lewis Published
-
Somero: trading this overlooked bargain
Features Mechanical-screed maker Somero dominates its niche and is attractively valued. Matthew Partridge picks the best way to trade it.
By Dr Matthew Partridge Published
-
How to find big profits in small companies
Cover Story The small- and micro-cap sectors are risky and volatile. But with careful research and patience, investors could make huge gains. Matthew Partridge explains how to find the market’s top tiddlers.
By Dr Matthew Partridge Published
-
The hidden gems on Aim, London's junior market
Features Aim, London’s junior market, is risky – but you can find solid stocks at low prices. Scott Longley reports.
By Scott Longley Published
-
Is Aim finally coming of age?
Features The Aim market of mostly smaller companies has traditionally been seen as a bit of a backwater. Is it time to change that view? Matthew Partridge talks to Paul Latham and Richard Power of fund management company Octopus.
By Dr Matthew Partridge Published
-
Fetch! The Chinese small-cap stocks to buy in the Year of the Dog
Opinion Each week, a professional investor tells us where she’d put her money. This week: Tiffany Hsiao of Matthews Asia selects three Chinese small-cap stocks with exciting potential.
By Tiffany Hsio Published
-
Small and mid-cap stocks with big potential
Opinion Professional investor Guy Anderson of the Mercantile Investment Trust selects three small and medium-sized firms with promising prospects that the market has missed.
By Guy Anderson Published
-
Get cheap, reliable growth from smaller companies
Features One of the most reliable long-term investment trends is the long-term outperformance of smaller companies over blue chips. Max King picks some of the best ways to buy into this growth.
By Max King Published
-
Big gains from small caps
Features In an environment of middling inflation and low interest rates, small-cap stocks tend to beat big blue-chips. John Stepek explains why, and how to invest in them.
By John Stepek Published